WHO recently named XBB1.16 a COVID-19 virus variant of interest, which means it has properties worth watching.
Analysis of the outbreak shed light on its origins and transmission patterns, and assessed treatment and infection control.
Encouraging immune-response and safety data emerge from preliminary human test of a genetically attenuated parasite vaccine.
The UW Medicine Virology Laboratory recently became one of the few clinical reference labs in the country to establish testing for monkeypox.
